Manufacturing, Cell-Line Selection

Apr 20, 2018
By BioPharm International Editors
The new platform is expected to speed up cell line development.
Mar 08, 2018
By BioPharm International Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Feb 20, 2018
By BioPharm International Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Dec 08, 2017
By BioPharm International Editors
Gilead Sciences will acquire Cell Design Labs to further cell-therapy research and development efforts.
Nov 02, 2017
By BioPharm International Editors
The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.
Oct 25, 2017
By BioPharm International Editors
ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.
Oct 16, 2017
By BioPharm International Editors
The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products.
Oct 12, 2017
By BioPharm International Editors
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
Oct 06, 2017
By BioPharm International Editors
Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.
Oct 01, 2017
BioPharm International
Detecting viral contaminants in biologic-based medicines—and identifying their source—requires a holistic testing approach.
native1_300x100
lorem ipsum